Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

The ongoing apaziquone P3 trial has gone to 'Active, not recruiting' on Sept 27th which is a year after they started the trial. Considering it took ~2.5 years to recruit ~1600 pts for the previous P3 trials this is basically saying they stopped the trial of 1869 pts. This is EXCELLENT! I've been advocating all along that if the FDA was not going to consider a new tool in the shed based on the work-up of the existing data Spectrum should stop the trial and conserve resources especially with a patent that may expire around the time the ongoing P3 finishes. If the FDA goes counter the advisory committee and gives it some kind of conditional approval they could always start recruiting again but there is a very slim chance of that happening.